Miyazaki, Japan

Tadashi Nagatani

This inventor holds 1 USPTO granted patent. Top assignee: Asahi Kasei Kogyo K.k.. Active years: 1992.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tadashi Nagatani. Retrieved from https://idiyas.com/inventor/tadashi-nagatani

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 1992

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Tadashi Nagatani

Introduction

Tadashi Nagatani is a notable inventor based in Miyazaki, Japan. He has made significant contributions to the field of medicinal chemistry, particularly through his work on pyridine derivatives. His innovative approach has led to advancements in psychotropic medicaments.

Latest Patents

Nagatani holds 1 patent for his invention related to novel pyridine derivatives and 1,2,3,4-tetrahydropyridine derivatives. This invention is characterized by specific general formulas that define the chemical structure and potential applications of these compounds. The derivatives are designed to be useful as psychotropic medicaments, showcasing their importance in medical science.

Career Highlights

Throughout his career, Nagatani has been associated with Asahi Kasei Kogyo K.K., where he has contributed to various research initiatives. His work has been instrumental in developing new therapeutic agents that can improve mental health treatments.

Collaborations

Nagatani has collaborated with notable colleagues, including Showa Ueki and Hiromu Kawakubo. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Tadashi Nagatani's contributions to the field of medicinal chemistry through his innovative work on pyridine derivatives highlight his role as a significant inventor. His ongoing research continues to pave the way for advancements in psychotropic medications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…